Raffaella Faraoni
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Synthesis and biological activity, Chemical Synthesis and Analysis
Most-Cited Works
- → A quantitative analysis of kinase inhibitor selectivity(2008)2,427 cited
- → A Catalytic Asymmetric Three‐Component 1,4‐Addition/Aldol Reaction: Enantioselective Synthesis of the Spirocyclic System of Vannusal A(2005)105 cited
- → Total Synthesis and Structural Revision of Vannusals A and B: Synthesis of the Originally Assigned Structure of Vannusal B(2010)65 cited
- → Identification of 1-(3-(6,7-Dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea Hydrochloride (CEP-32496), a Highly Potent and Orally Efficacious Inhibitor of V-RAF Murine Sarcoma Viral Oncogene Homologue B1 (BRAF) V600E(2011)58 cited
- → CEP-32496: A Novel Orally Active BRAFV600E Inhibitor with Selective Cellular and In Vivo Antitumor Activity(2012)47 cited
- → H-Bonded complexes of adenine with Rebek imide receptors are stabilised by cation–π interactions and destabilised by stacking with perfluoroaromatics(2004)29 cited
- → New Rebek imide-type receptors for adenine featuring acetylene-linked π-stacking platforms(2004)17 cited
- → 4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitors(2011)13 cited
- → Supplementary Data 1 from CEP-32496: A Novel Orally Active BRAF<sup>V600E</sup> Inhibitor with Selective Cellular and <i>In Vivo</i> Antitumor Activity(2023)